1. Home
  2. TREE vs FULC Comparison

TREE vs FULC Comparison

Compare TREE & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$38.26

Market Cap

541.5M

Sector

Finance

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.73

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREE
FULC
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.5M
467.8M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
TREE
FULC
Price
$38.26
$3.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$71.25
$16.38
AVG Volume (30 Days)
204.1K
4.5M
Earning Date
04-30-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
N/A
EPS
1.22
N/A
Revenue
$1,117,324,000.00
N/A
Revenue This Year
$19.03
N/A
Revenue Next Year
$7.07
N/A
P/E Ratio
$30.11
N/A
Revenue Growth
24.12
N/A
52 Week Low
$32.65
$2.83
52 Week High
$77.35
$15.74

Technical Indicators

Market Signals
Indicator
TREE
FULC
Relative Strength Index (RSI) 51.29 34.08
Support Level $34.05 $2.83
Resistance Level $40.00 $8.34
Average True Range (ATR) 1.96 0.24
MACD 0.30 0.11
Stochastic Oscillator 69.79 61.49

Price Performance

Historical Comparison
TREE
FULC

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: